Transcription of INJECTABLE MEDICATIONS FEE SCHEDULE ONCOLOGY …
{{id}} {{{paragraph}}}
Example: tourism industry
INJECTABLE MEDICATIONS FEE SCHEDULE ONCOLOGY …
CODEDESCRIPTIONMAX QTYRATECOMMENTS/NOTESC9492 DURVALUMAB J0594 busulfan J0640 LEUCOVORIN CALCIUM J0641 LEVOLEUCOVORIN CALCIUM J0881 DARBEPOETIN ALFA NON-ESRD USEJ0882 DARBEPOETIN ALFA ESRD ON DIALYSISJ0885 EPOETIN ALFA 1,000 NON-ESRD USEJ0894 DECITABINE J0897 DENOSUMAB J1050 MEDROXYPROGESTERONE ACETATE 1MG1, J1190 DEXRAZOXANE HCL J1260 DOLASETRON MESYLATE G-CSF J1447 TBO FILGRASTIM J1453 FOSAPREPITANT J1457 GALLIUM NITRATE HYDROCHLORIDE J1640 HEMIN J1930 LANREOTIDE J2355 OPRELVEKIN HCL J2430 PAMIDRONATE DISODIUM PER J2469 PALONOSETRON J2505 PEGFILGRASTIM 6MG15, J2562 PLERIXAFOR J2783 RASBURICASE J2820 SARGRAMOSTIM (GM-CSF) J3240 THYROTROPIN ALPHA J3315 TRIPTORELIN PAMOATE J3489 ZOLEDRONIC ACID INJECTABLE MEDICATIONS FEE SCHEDULE
code description max qty rate comments/notes j0207 amifostine 500mg 3 469.48 j0594 busulfan 1mg 60 32.49 j0640 leucovorin calcium 50mg 20 5.35
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Chemical Compatibility: Busulfan, TREANDA ® bendamustine HCI solution, Busulfan, EXTRAVASATION, AX#Pharmaceutical#Corp#Product#List, Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer, Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer Health, NF29 Inhaltsverzeichnis United States Pharmacopeia, Virtuelle Fachbibliothek Pharmazie - ViFaPharm Rechercheauftrag, Extravasation Classification of Systemic Anti